Jazz Pharmaceuticals plc — Director's Dealing 2024

Jun 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2024-06-07

Reporting Person: Carr Patricia (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-07	Ordinary Shares	S	163	$108.825	Disposed	6596	Direct

Footnotes

F1: 163 ordinary shares were acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan.